Vanguard Group Inc Atossa Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,598,296 shares of ATOS stock, worth $6.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,598,296
Previous 6,485,877
1.73%
Holding current value
$6.8 Million
Previous $7.72 Million
29.94%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ATOS
# of Institutions
89Shares Held
26.5MCall Options Held
466KPut Options Held
91.8K-
Black Rock Inc. New York, NY9.2MShares$9.47 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.81MShares$2.9 Million0.0% of portfolio
-
State Street Corp Boston, MA1.73MShares$1.78 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.31MShares$1.35 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL954KShares$982,8240.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $130M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...